Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8137966 | Rat embryonic stem cell The present invention provides a rat embryonic stem cell characterized by having the following properties of (a) expressing Oct3/4 gene and Nanog gene, (b) positive for alkaline phosphatase activity, (c) having an embryoid body forming ability, (d) expressing SSEA (... | 03/20/2012 |
| 7381560 | Expression and use of anti-CD20 antibodies Disclosed are immunologically active antibodies directed against the CD20 antigen, as well as host cells comprising nucleic acid sequences encoding the light chains and heavy chains of immunologically active antibodies wherein the cell is capable of expressing and s... | 06/03/2008 |
| 7316926 | Immortalized vascular adventital cell line To provide an immortalized capillary pericyte line which maintains the original function/property of the cell line-deriving tissue, its establishment method, and the screening method for useful substance using the immortalized capillary pericyte line. Cerebral tissu... | 01/08/2008 |
| 7303915 | In vitro-differentiated retinal ganglion cells and method for producing same In vitro-differentiated retinal ganglion cells can be produced by exposing a mammalian retinal ganglion cell line to a protein kinase inhibitor. The differentiated retinal ganglion cells can be used to identify agents that protect retinal ganglion cells in vivo or i... | 12/04/2007 |
| 7300763 | Method of testing myelotoxicity with the use of flow cytometer The objects of the present invention are to solve low test efficiency and low accuracy which are problems encountered in the conventional methods for testing myelotoxicity of a drug by observing smears. To this end, markers for discriminating and identifying hematop... | 11/27/2007 |
| 7291458 | Leptin-mediated gene-induction Methods of activating a signaling cascade comprising, introducing leptin and/or a cytokine to a receptor complex comprising gp 130, optionally in combination with a compound acting on adenylate cyclase or acting on one or more downstream targets of adenylate cyclase... | 11/06/2007 |
| 7291499 | Transformed cell, method of screening anti-aging agent and anti-aging agent This invention provides a novel transformed cell useful in constructing an anti-aging agent screening system, a screening method which uses the same and an anti-aging agent, and it relates to a transformed cell in which a gene coding for (a) a protein capable of pho... | 11/06/2007 |
| 7279330 | Method for identifying modulating compounds of neurotransmitters A process for identifying compounds that can modulate the release of neuromediators is described in which, for example, at least one compound that is to be tested is brought into contact with a nerve tissue preparation and the possible modulating effect of the compo... | 10/09/2007 |
| 7253150 | Gene delivery vehicle expressing the aptosis-inducing proteins VP2 and/or apoptin The invention relates to gene delivery vehicles which comprise nucleic acid molecules encoding apoptosis-inducing proteins VP2 and/or apoptin (VP3) like activity. VP2 and VP3 are viral proteins of the Chicken Anaemia Virus. Also, the invention relates to anti-tumor ... | 08/07/2007 |
| 7186812 | Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof The present invention provides amino acid sequences of peptides that are encoded by genes within the Human genome, the GPCR peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identif... | 03/06/2007 |
| 7176284 | Osteogenic proteins Disclosed are (1) osteogenic devices comprising a matrix containing substantially pure natural-sourced mammalian osteogenic protein; (2) DNA and amino acid sequences for novel polypeptide chains useful as subunits of dimeric osteogenic proteins; (3) vectors carrying... | 02/13/2007 |
| 7169612 | Use of EDG2 receptor in an animal model of heart failure Mammals and myocardial mammal cells transformed with G protein coupled receptor EDG2 are presented for use in an animal model for heart failure. ... | 01/30/2007 |
| 7157261 | Rat secreted embryonic alkaline phosphatase Rat secreted embryonic alkaline phosphatase and methods for it use are provided. ... | 01/02/2007 |
| 7157244 | Adenosine receptor The present invention provides an isolated mammalian adenosine receptor, isolated or recombinant nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods of making the receptor using the host cells. Th... | 01/02/2007 |
| 7060869 | Fluorescent protein sensors for detection of analytes Fluorescent indicators including a binding protein moiety, a donor fluorescent protein moiety, and an acceptor fluorescent protein moiety are described. The binding protein moiety has an analyte-binding region which binds an analyte and causes the indicator to chang... | 06/13/2006 |
| 7052690 | Culture of goblet cells The invention encompasses isolation, culture and characterization of goblet cells in vitro form mammalian conjuctiva. Goblet cells can be cultured from conjunctiva of such mammals as, e.g., humans, rats, mice, rabbits and the like. In another aspect of the invention... | 05/30/2006 |
| 7029915 | Method for differentiating rat hepatic stem cells to insulin-producing cells Highly purified hepatic stem cells are trans-differentiated into pancreatic endocrine hormone-producing cells by culturing them in vitro in a medium containing high levels of glucose. These trans-differentiated cells express insulin, glucagon, and pancreatic polypep... | 04/18/2006 |
| 7005411 | Method for modulating nerve cell function The amount of active Robo expressed on a cell is modified by modulating the effective amount of a Comm polypeptide in contact with the cell, whereby the amount of expressed active Robo is modulated inversely with the modulation of the effective amount of the Comm po... | 02/28/2006 |
| 6969608 | Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors Current sources of neural stem and progenitor cells for neural transplantation are essentially inaccessible in living animals. This invention relates to neural precursor cells (stem cells, progenitor cells or a combination of both types of cells) isolated from the o... | 11/29/2005 |
| 6960472 | Monoclonal antibodies against N-Terminus proBNP Monoclonal antibodies having high affinity for N-terminus pro brain natriuretic peptide (NT-proBNP) are described. The monoclonal antibodies are prepared against a synthetic peptide having the Sequence ID No. 1. Specifically, the monoclonal antibodies described are ... | 11/01/2005 |
| 6956114 | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase The present invention relates to the field of DNA recombinant technology. More specifically, this invention relates to fusion proteins comprising an ATP generating polypeptide joined to a polypeptide that converts ATP into a detectable entity. Accordingly, this inve... | 10/18/2005 |
| 6946260 | Allergen/inflammatory testing and diagnosis The invention relates to the use of a secretor variant cell-line expressing the alpha moiety of human IgE binding protein to determine the allergic status of a given individual. Moreover, the cell-line is also used to provide an assay system for determining the alle... | 09/20/2005 |
| 6943016 | Human adult astrocytes, their preparation and uses thereof The invention provides an essentially pure preparation of human adult astrocytes, and a method of producing same. The purified astrocytes are useful for the treatment of neurodegenerative disorders or trauma to the central nervous system. ... | 09/13/2005 |
| 6919308 | Osteogenic devices Disclosed are (1) osteogenic devices comprising a matrix containing substantially pure natural-sourced mammalian osteogenic protein; (2) DNA and amino acid sequences for novel polypeptide chains useful as subunits of dimeric osteogenic proteins; (3) vectors carrying... | 07/19/2005 |
| 6916642 | Vertebrate telomerase genes and proteins and uses thereof Nucleic acid molecules encoding vertebrate telomerase are provided. Gene products, expression vectors and host cells suitable for expressing telomerase are also provided. Methods for identifying inhibitors of telomerase activity and inhibitor compositions are disclo... | 07/12/2005 |
| 6897061 | Transdifferentiation of glial cells A process for generating multipotent cells from glial cells using in vitro techniques to dedifferentiate fetal or adult mammalian glial cells into multipotent cells. The multipotent cells may further be differentiated into particular types of nervous system cells, i... | 05/24/2005 |
| 6878544 | Retinal cell lines with extended life-span and their applications The invention features retina-derived (retinal endothelial or retinal epithelial pigment) cell lines with extended life-span and capable of being implanted in the retina and of carrying a therapeutic substance to the eye and to the central nervous system. Such lines... | 04/12/2005 |
| 6835567 | PNS cell lines and methods of use therefor Conditionally-immortalized PNS progenitor cell lines are provided. Such cell lines, which may be clonal, may be used to generate neurons. The cell lines and/or differentiated cells may be used for the development of therapeutic agents to prevent and treat a variety ... | 12/28/2004 |
| 6803233 | Model for Alzheimer's disease and other neurodegenerative diseases The present invention provides a model for studying the development of, and/or pathologies associated with neurodegenerative diseases, and agents that can alter such development and/or pathologies. The model of the invention is especially useful as an Alzheimer's di... | 10/12/2004 |
| 6673605 | Established cell line of microglia The present invention relates to an established cell line of microglia having the following properties: (a) form: having a macrophage-like or globular form in the presence of granulocyte-macrophage colony-stimulating factor. and in the absence of said... | 01/06/2004 |
| 6670182 | Assays for ଲ-amyloid processing The invention relates to the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of ଲ-amyloid processing. More specifically, the invention relates to in vitro assays capable of identifying or quantifying ... | 12/30/2003 |
| 6641526 | Development of normal offspring from oocytes injected with freeze-dried spermatozoa The invention provides a method for freeze-drying spermatozoa to obtain at least one reconstituted spermatozoon whose head (nucleus) is capable of fertilizing an oocyte to produce a live offspring. The motility of spermatozoa which have been freeze-dried ... | 11/04/2003 |
| 6638738 | Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the lipase peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, metho... | 10/28/2003 |
| 6573041 | Neuronal cell model and methods of use thereof We previously described a novel in vitro model of a non-productive herpes simplex virus type 1 (HSV-1) infection in neurally-differentiated (ND)-PC12 cells that allows for inducible virus replication upon forskolin and heat stress (HS) treatment. In this ... | 06/03/2003 |
| 6555674 | JeT promoter The JeT promoter is a recombinant promoter with transcriptional activity comparable to a number of strong mammalian promoters. The promoter consists of five key elements: (1) a TATA box; (2) a transcription initiation site (Inr); (3) a CAT consensus seque... | 04/29/2003 |
| 6541247 | Method of isolating ependymal neural stem cells The present invention relates to a method of isolating ependymal neural CNS stem cells from a post-natal animal or a human, which method comprises the steps of (a) screening single cells obtained by dissociating CNS tissue from said animal for cells exhib... | 04/01/2003 |
| 6506599 | Method for culturing langerhans islets and islet autotransplantation islet regeneration A method for culturing Langerhans islets to obtain an amount sufficient for transplant and autotransplant is disclosed. The islets are cultured in a culture serum (rat/human) medium which is supplemented with radical scavengers, growth factors, a matrix m... | 01/14/2003 |
| 6475718 | Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus The orphan seven transmembrane domain receptor, APJ, can function as a coreceptor for cellular infection by the HIV virus. The establishment of cell lines that coexpress CD4 and APJ provide valuable tools for continuing research on HIV infection and the d... | 11/05/2002 |
| 6451549 | Secreted renilla luciferase A polynucleotide encoding a secreted form of wild type Renilla luciferase. Also provided is a polynucleotide encoding a secreted modified form of wild type Renilla luciferase. Additionally, the polypeptides encoded by the polynucleotides of the present in... | 09/17/2002 |
| 6372956 | Transgenic rats and rat cell lines expressing human CD4 and a human chemokine receptor The present invention features transgenic rodent models for HIV, wherein the transgenic rodent or transgenic rodent cell has incorporated into its genome genes encoding a human CD4 receptor and a human chemokine receptor. In particular the invention relat... | 04/16/2002 |
